Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Constellation Brands
STZ
US Stock MarketDetailed Quotes
MURA Mural Oncology
- 1.220
- -0.040-3.17%
Trading Apr 1 10:12 ET
21.02MMarket Cap-0.16P/E (TTM)
1.248High1.195Low34.85KVolume1.240Open1.260Pre Close42.71KTurnover0.28%Turnover RatioLossP/E (Static)17.23MShares4.74052wk High0.15P/B15.49MFloat Cap1.11052wk Low--Dividend TTM12.69MShs Float57.200Historical High--Div YieldTTM4.21%Amplitude1.110Historical Low1.225Avg Price1Lot Size
About Mural Oncology Company
Mural Oncology Plc is a clinical-stage oncology company, which engages in the business of discovering and developing immunotherapies for patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.
Company Profile
SymbolMURA
Company NameMural Oncology
Listing DateNov 6, 2023
Founded2017
CEODr. Caroline Loew, PhD
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address10 Earlsfort Terrace
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-905-8020
Websitehttp://www.muraloncology.com
Company Executives
- Name
- Position
- Salary
- Dr. Caroline Loew, PhD
- Chief Executive Officer and Director
- 2.52M
- Vicki L. Goodman
- Chief Medical Officer
- 705.58K
- Maiken Keson-Brookes
- Chief Legal Officer
- --
- Adam D. Cutler
- Chief Financial Officer and Principal Accounting Officer
- 743.18K
- Scott T. Jackson, M.B.A.
- Chairman of the Board
- 65.97K
- Sachiyo Minegishi, M.B.A.
- Independent Director
- --
- Benjamin J. Hickey, M.B.A.
- Independent Director
- 51.79K
- Dr. George S. Golumbeski, PhD
- Independent Director
- --
- Dr. Francis M. Cuss, F.R.C.P.,M.B.
- Independent Director
- 58.63K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
